Validation of the Dutch Translation of the Tobacco, Alcohol, Prescription Medication and Other Substances (TAPS)-Tool

Launched by BIRGIT SEELEN-DE LANG · Mar 4, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the Dutch version of a tool called the TAPS-tool, which helps assess substance use in patients with severe mental disorders and intellectual disabilities. The goal is to see how reliable and valid this tool is when used with two different groups of patients: those without intellectual disabilities who are receiving treatment from special community care teams, and those with intellectual disabilities, for whom the tool will be adjusted to better fit their needs. The results from the TAPS-tool will be compared to a well-established standard to ensure accuracy.

To participate in this trial, you need to be a patient receiving treatment at specific community care teams or at a department that focuses on patients with both intellectual disabilities and mental health issues. All ages are welcome, and both men and women can participate. However, if someone cannot speak Dutch well or has trouble concentrating for about 20 minutes, they won't be able to take part. Participants can expect to help improve a valuable assessment tool that could benefit many others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients treated in the participating FACT teams and for patients treated at the LVB-P (department for patients with intellectual disabilities and psychiatric disorders \[Dutch name\]) department of the GGZ Oost Brabant or the ORO foundation (ORO is no abbreviation but just a name of the institute).
• Exclusion Criteria:
• • If patients do not have sufficient command of the Dutch language or cannot concentrate for 20 minutes, the instruments are not taken